Beingmate pivots to family nutrition after state takeover, loses 334 dealers in half year
Chinese infant formula maker Beingmate, now under Jinhua state-owned control, outlined a strategy to build a "second growth curve" by expanding into full-family nutrition, including diapers and elderly products. The company reported a challenging first half of 2026, with revenue down 4.63% to 1.292 billion yuan and net profit down 3.60%. Its dealer network shrank by 21.15% to 1,245. Competition in infant formula has shifted from price wars to R&D, omnichannel services, and brand mindshare.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Common ground
- Both agents agree that Western media and analysts apply a double standard, calling Chinese innovation 'desperate diversification' while praising similar moves by Western companies as 'cutting-edge science'.
- Both acknowledge that Chinese companies like Beingmate are building parallel supply chains as a hedge against Western trade weaponization, a survival response to geopolitical risks.
- Both recognize that China's demographic challenges, like declining birth rates, are real and that Beingmate's pivot to whole-family nutrition is a direct response to that reality.
Points of contention
- The Eastern agent sees the 40% drop in dealer revenue as healthy market consolidation that eliminates inefficient middlemen, while the regional agent views it as crushing small shop owners and local livelihoods.
- The Eastern agent argues state capital injection is strategic patience and a competitive advantage, while the regional agent calls it political favoritism that picks winners and crushes smaller companies.
- The Eastern agent frames China's market evolution as democratizing access for 1.4 billion consumers, while the regional agent says it centralizes wealth and reduces consumer choice for niche needs.
- The regional agent claims the omnichannel model relies on surveillance infrastructure tracking every purchase, while the Eastern agent says this is no different from digital tracking in any modern economy.
Blind spots
- Neither agent fully addresses how the pivot to whole-family nutrition might fail if consumer trust in domestic brands remains fragile after the melamine scandal.
- Both overlook the potential environmental and supply chain risks of building 'China-only' supply chains, such as higher costs or resource strain.
- The discussion ignores the role of foreign competitors like Nestlé and Danone in shaping Beingmate's strategy, treating them as passive rather than active players in the market.
WorldAttention’s read
This debate shows that Beingmate's transformation is a story of adaptation under pressure, but it's not a simple success or failure. Both agents agree that Western bias against Chinese innovation is real and unfair. However, they clash sharply on the human cost: the Eastern agent sees efficiency gains and long-term benefits for consumers, while the regional agent warns that this model crushes small businesses and centralizes wealth. A key blind spot is whether this pivot can rebuild consumer trust after past scandals, and whether 'China-only' supply chains are sustainable. Ultimately, Beingmate's strategy is a survival move in a tough market, but whether it's true innovation or just consolidation dressed up as progress depends on whose voice you listen to — the company's or the people left behind.
Reporting timeline
Beingmate Says Probiotics and Protein Drink Markets Still Growing but Entering Slower, Competitive Phase
In a September 24 investor relations session, Beingmate (002570.SZ) addressed questions about its second growth curve amid rising competition in the nutrition category. The company stated that the probiotics and protein beverage industries are still growing, but have shifted from rapid expansion to medium-to-low growth and product homogenization competition. Current competitive focus is moving toward patented strains, protein sources, flavors, and usage scenarios. Beingmate confirmed it is not absent from these segments: it has developed functional and differentiated protein powder products under its 'Whole Family Nutrition' R&D category, and has launched the 'Life No.1' and 'Life No.2' probiotic series. The response reflects the company's strategic positioning in a maturing market.
Beingmate Outlines Post-State-Capital Strategy to Analysts, Targets Second Growth Curve
On September 23, Beingmate (002570) held its first institutional survey since state capital (Jinhua State-owned Assets) took control, with founder Xie Hong presenting the company's development history, core advantages, and future strategy. The company outlined a plan to build a technology-driven professional consumer goods company, focusing on four business modules: maternal and infant ecology, whole-family nutrition, whole-family health, and a better life. It will employ four business models: OBM, ODM, OEM, and brand licensing. To counter declining birth rates, Beingmate plans to expand beyond infant formula into products like diapers for 0-3 year olds and nutrition products for middle-aged and elderly consumers. The company emphasized prioritizing profit quality and achieving profitable market share growth. It noted the infant formula industry is in a phase of stock competition and structural upgrades, with competition shifting from price wars to R&D, channel services, and brand loyalty. Beingmate also confirmed its probiotic and protein powder products are under development or already on the market. The company detailed its approach to balancing its own brands with distribution and co-packing models, and outlined three strategies to improve profitability: optimizing organizational structure, strictly evaluating marketing spending, and building a super brand portfolio.
Read sourceBeingmate Says Infant Formula Competition Shifts from Price War to Comprehensive Battle
According to a report by Cailianshe on September 24, Beingmate (贝因美) stated during a recent institutional survey that the infant formula (婴配粉) industry is currently in a phase of parallel stock competition and structural upgrading. Industry concentration is continuously increasing, and the competitive focus has shifted from price wars to a comprehensive contest involving formula research, omnichannel services, and brand mindshare. Based on its strategic plan, Beingmate will continue to capture market share and increase customer total spending on one hand, while on the other hand, it will persist in using maternal and infant customers as the traffic origin, leveraging technology to deeply engage users, and extending towards a comprehensive enterprise oriented towards family professional consumption.
Show 3 older updatesHide older updates
Beingmate Says Infant Formula Competition Shifts from Price Wars to Comprehensive Rivalry
According to a report by People's Financial News on September 24, Beingmate (002570) stated during a recent institutional investor survey that the infant formula industry is currently in a phase of parallel stock competition and structural upgrading. Industry concentration is continuously increasing, and the focus of competition has shifted from price wars to a comprehensive contest involving formula research, omnichannel services, and brand mindshare. Based on its strategic plan, the company will continue to capture market share and increase customer total spending, while also using mothers and infants as the traffic origin, leveraging technology to deeply engage users, and extending towards a comprehensive enterprise oriented towards family professional consumption.
Read sourceBeingmate Says Infant Formula Competition Shifts from Price War to Comprehensive Competition
According to a report from Stockstar Securities News on September 24, Beingmate (002570) stated during a recent institutional investor survey that the infant formula industry is currently in a phase of parallel stock competition and structural upgrading. Industry concentration is continuously increasing, and the competitive focus has shifted from price wars to comprehensive competition in formula research, omnichannel services, and brand mindshare. Based on its strategic plan, Beingmate will continue to capture market share and increase customer total spending on one hand, while on the other hand, it will persist in using maternal and infant care as a traffic origin, leveraging technology to deeply engage users, and extending towards a comprehensive enterprise oriented towards family professional consumption.
Read sourceBeingmate loses 334 dealers in half year, pivots to family nutrition after state-owned takeover
Chinese infant formula maker Beingmate is undergoing a major transformation after its controlling shareholder's restructuring plan was approved, transferring control to Jinhua State-owned Assets Supervision and Administration Commission. In a recent investor survey, Beingmate management outlined a strategy to build a 'second growth curve' by expanding beyond infant formula into full-family nutrition, targeting 0-3 year old products like diapers and nutritional products for the elderly. The company reported a challenging first half of 2026, with revenue falling 4.63% to 12.92 billion yuan and net profit down 3.60%. Its dealer network shrank sharply by 21.15% to 1,245, with dealer/direct-supply revenue plunging 40.07%. However, the exclusive distributor model grew to 65.18% of revenue with improved margins. Beingmate's stock has fallen nearly 30% year-to-date. The company expects to benefit from Jinhua's '15th Five-Year Plan' which prioritizes the life health industry chain.